This inventor holds 5 USPTO granted patents. Top assignees: Pacific Northwest Research Foundation, Pacific Northwest Research Institute. Active years: 1997-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-2001
Title: The Innovative Contributions of Donald C. Malins
Introduction
Donald C. Malins is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of cancer research, particularly in the development of methods for differentiating between metastatic and non-metastatic tumors. With a total of 5 patents, his work has the potential to impact cancer diagnosis and treatment.
Latest Patents
Among his latest patents, Malins has developed methods for screening tumors and tumor progression to the metastatic state. These innovative screening methods utilize the characterization of DNA through principal components analysis of spectral data obtained from Fourier transform-infrared spectroscopy of DNA samples. The applicability of these methods spans a wide variety of DNA samples and cancer types. Furthermore, a model he developed using multivariate normal distribution equations and discriminant analysis is particularly effective in distinguishing primary cancerous tissue from metastatic cancerous tissue.
Career Highlights
Throughout his career, Donald C. Malins has worked with notable organizations such as the Pacific Northwest Research Foundation and the Pacific Northwest Research Institute. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Due to space constraints, the details of his collaborations will not be included.
Conclusion
Donald C. Malins continues to be a significant figure in cancer research, with his innovative methods paving the way for advancements in tumor screening and differentiation. His contributions are vital to improving cancer diagnosis and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile